All In MedTech

Device Trial Radar · NCT05966662

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Prospective, Multicenter, Single-Arm IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD Duo Study)

Last checked: Nov 20, 2026Latest source record: Feb 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

145

Actual

Start

Dec 8, 2023

Primary completion

Jan 9, 2025

Study completion Dec 19, 2025

Sponsor

Lead sponsor
Shockwave Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 1, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This investigational device exemption (IDE) study is to assess the safety and effectiveness of the Shockwave Coronary Intravascular Lithotripsy (IVL) System with the Shockwave C2+ 2Hz Coronary IVL Catheter to treat de novo, calcified, stenotic, coronary lesions prior to stenting.

Conditions

  • Coronary Artery Disease
  • Myocardial Infarction

Interventions

  • IVL with Shockwave C2+ 2Hz Coronary IVL CatheterDevice

    Lithotripsy-enabled, low-pressure balloon dilatation of severely calcified, stenotic de novo coronary arteries prior to stenting.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Experienced Freedom From Major Adverse Cardiac Events (MACE) Within 30 Days Post-procedureTime frame: within 30 days of index procedure
  2. Percentage of Participants With Procedural Success (Residual Stenosis ≤30%)Time frame: 12-24 hours post procedure or at discharge, whichever is earlier, but at least 6 hours post procedure

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Heart Center Research

    Huntsville, Alabama

  • Scripps Clinic

    La Jolla, California

  • Medstar Washington Hospital Center

    Washington D.C., District of Columbia

15 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.